Resistance treatment of Vigabatrin

Vigabatrin is a drug used to treat epilepsy, but some patients may develop resistance to the drug. Drug resistance means that the effect of the drug on the patient's disease is weakened or ineffective, and corresponding resistance treatment measures need to be taken. Sometimes increasing or decreasing the dose of a drug can improve tolerance. This needs to be done under the guidance of a doctor, as dosage adjustments should be determined based on the patient's specific situation.

Vigabatrin is an anti-epileptic drug approved for drug-resistant epilepsy. For patients who may develop drug resistance, it is important to regularly monitor drug efficacy and seizure frequency. If vigabatrin is combined with other antiepileptic drugs to improve treatment efficacy, such combination therapy may have an inhibitory effect on drug resistance, but choosing an appropriate combination requires medical advice. If vigabatrin completely fails or is not tolerated, your doctor may consider alternative treatment options, such as other anti-epileptic drugs, surgery, or other treatments.

The original Vigabatrin drug has not yet been launched in China, so it is not included in medical insurance. The Hong Kong version of the specificationsThe price of 500mg*100 bags per box may be more than 1,000 yuan (the price may fluctuate due to exchange rate effects). It is reported that an Indian chemical generic drug vigabatrin powder is on the domestic market. The price of each box of 500mg*50 bags may be more than 3,000 yuan. Its pharmaceutical ingredients are basically the same as those of the original drug. The Turkish version of Vigabatrin currently sold overseas may cost more than RMB 1,000 per box of 500mg*100 bags (the price may fluctuate due to exchange rates).